182 related articles for article (PubMed ID: 10690526)
1. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
2. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
Ross JA; Schmidt PT; Perentesis JP; Davies SM
Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
[TBL] [Abstract][Full Text] [Related]
3. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues.
Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM
Digestion; 1999; 60(5):477-83. PubMed ID: 10473973
[TBL] [Abstract][Full Text] [Related]
4. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
[TBL] [Abstract][Full Text] [Related]
5. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
[TBL] [Abstract][Full Text] [Related]
7. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts.
Kiess W; Paquette J; Koepf G; Wolf E; Deal C
Biochem Biophys Res Commun; 1999 Feb; 255(2):226-30. PubMed ID: 10049690
[TBL] [Abstract][Full Text] [Related]
10. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
11. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
12. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
13. IGF2 but not H19 shows loss of imprinting in human glioma.
Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
[TBL] [Abstract][Full Text] [Related]
14. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
15. No loss of genomic imprinting of IGF-II and H19 in placentas of diabetic pregnancies with fetal macrosomia.
Vambergue A; Fajardy I; Dufour P; Valat AS; Vandersippe M; Fontaine P; Danze PM; Rousseaux J
Growth Horm IGF Res; 2007 Apr; 17(2):130-6. PubMed ID: 17306581
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
Wada M; Seeger RC; Mizoguchi H; Koeffler HP
Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
[TBL] [Abstract][Full Text] [Related]
17. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
19. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
[TBL] [Abstract][Full Text] [Related]
20. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
